These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6243171)

  • 1. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS; Bethune JE
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexamethasone in nonsuppressible Cushing's disease.
    Meikle AW; West CD; Tyler FH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 6247657
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone in nonsuppressible Cushing's disease.
    Wortsman J; Blank JH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 7383133
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
    Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 7. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of Cushing's syndrome].
    Laurencet FL; Jenny M; Muller AF
    Schweiz Rundsch Med Prax; 1970 Oct; 59(42):1454-67. PubMed ID: 4321069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical response to dexamethasone-suppression in Cushing's disease with adrenal hyperplasia.
    Winkler G; Huhnstock K; Graef V
    Rass Neurol Veg; 1969; 23(5):187-93. PubMed ID: 4328312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effect of steroids on the secretion of ACTH in the hypothalamo-hypophyseal Cushing syndrome following adrenalectomy].
    Fehm HL; Voigt KH; Beinert KE; Lang R; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1907-9. PubMed ID: 197738
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
    Tsan KW; Kuo CY
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):936-43. PubMed ID: 3001216
    [No Abstract]   [Full Text] [Related]  

  • 14. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 16. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE; Westbie DK; Daly R; Bower RH
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) and dexamethasone on the suppression of the hypothalamo-pituitary-adrenal system.
    Berthold K; Arimura A; Schally AV
    Acta Endocrinol (Copenh); 1970 Mar; 63(3):423-30. PubMed ID: 4317301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
    Marova EI; Butrova SA; Kolesnikova GS
    Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.